Product Information
MIDAZOLAM HCL 10 MG/2 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.5053 per ML under NDC 00641606325. Its NADAC has been published 57 times since Jul 23, 2025.
FDA first approved this application on Jun 20, 2000. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641606325
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
2/18/2026
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075243FDA Approved
6/20/2000
TE Code
AP
On Market Since
6/20/2000
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 10 MG/2 ML VIAL has been published 57 times since Jul 23, 2025, and over the history we have for it it has declined 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5053 per ML |
|---|---|
| All-time high | $0.5265 (Dec 10, 2025) |
| All-time low | $0.5053 (Feb 18, 2026) |
| 52-week high | $0.5265 |
| 52-week low | $0.5053 |
| Median price | $0.5194 |
| Average price | $0.5146 |
| Largest weekly change | -2.7% (Feb 18, 2026) |
| Weeks tracked | 57 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 10 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 10 MG/2 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.5053 per ML (NDC 00641606325), effective Aug 19, 2026.
How has the price of MIDAZOLAM HCL 10 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 10 MG/2 ML VIAL has declined 3.6%. It has been tracked across 57 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 10 MG/2 ML VIAL?
Since Jul 23, 2025, the NADAC for MIDAZOLAM HCL 10 MG/2 ML VIAL has ranged from a low of $0.5053 (Feb 18, 2026) to a high of $0.5265 (Dec 10, 2025), with a median of $0.5194 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 10 MG/2 ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIDAZOLAM HCL 50 MG/10 ML VIAL, is $0.3817 per ML — about 24% below MIDAZOLAM HCL 10 MG/2 ML VIAL.
Who manufactures MIDAZOLAM HCL 10 MG/2 ML VIAL?
MIDAZOLAM HCL 10 MG/2 ML VIAL (NDC 00641606325) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.